Insider Transactions in Q2 2022 at Kezar Life Sciences, Inc. (KZR)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 23
2022
|
Christopher J. Kirk CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,060
+7.98%
|
$0
$0.9 P/Share
|